Recently stock market analysts have updated their consensus ratings on shares of ABIOMED, Inc. (NASDAQ:ABMD). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

05/04/2016 – ABIOMED, Inc. had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 125 price target on the stock.

02/05/2016 – ABIOMED, Inc. had its “neutral” rating reiterated by analysts at Piper Jaffray. They now have a USD 90 price target on the stock.

02/04/2016 – ABIOMED, Inc. had its “buy” rating reiterated by analysts at Benchmark. They now have a USD 145 price target on the stock.

10/30/2015 – ABIOMED, Inc. was upgraded to “outperform” by analysts at Raymond James. They now have a USD 85 price target on the stock.

10/29/2015 – ABIOMED, Inc. had its “hold” rating reiterated by analysts at BTIG Research.

10/29/2015 – ABIOMED, Inc. had its “buy” rating reiterated by analysts at Sterne Agee.

08/17/2015 – CRT Capital began new coverage on ABIOMED, Inc. giving the company a “buy” rating.

08/12/2015 – ABIOMED, Inc. had its “overweight” rating reiterated by analysts at Stephens. They now have a USD 128 price target on the stock.

08/12/2015 – ABIOMED, Inc. had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 125 price target on the stock.

08/05/2015 – ABIOMED, Inc. had its “market perform” rating reiterated by analysts at Northland Securities. They now have a USD 80 price target on the stock.

05/04/2015 – ABIOMED, Inc. was downgraded to “hold” by analysts at Zacks.

01/29/2015 – ABIOMED, Inc. had its “outperform” rating reiterated by analysts at William Blair.

01/10/2014 – ABIOMED, Inc. had its “buy” rating reiterated by analysts at Wunderlich. They now have a USD 35 price target on the stock.

ABIOMED, Inc. has a 50 day moving average of 96.54 and a 200 day moving average of 86.94. The stock’s market capitalization is 4.03B, it has a 52-week low of 59.04 and a 52-week high of 110.68.

The share price of the company (NASDAQ:ABMD) was up +0.18%, with a high of 95.95during the day and the volume of ABIOMED, Inc. shares traded was 503750.

View other investors thoughts on ABIOMED, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.